LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy ...

Equities research analysts at William Blair decreased their Q3 2025 earnings estimates for Medpace in a research report ...

Analysts at William Blair raised their Q1 2025 EPS estimates for shares of Medpace in a research note issued to investors on ...

Highlights,Mirae Asset Global Investments Co. Ltd. reduced its stake in Medpace Holdings by 10.5%.,Institutional investors ...

Q4 2024 Earnings Call Transcript February 11, 2025 Operator: And good day, ladies and gentlemen, and welcome to the Medpace ...

Medpace forecasts 2025 revenue between $2.11 billion and $2.21 billion, representing flat to 4.8% growth. EBITDA is expected in the range of $462 million to $492 million, reflecting a potential ...

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 8.7% in the pre-market session after the company ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On ...

Medpace Holdings Inc (NASDAQ:MEDP) reported fourth-quarter financial results after the market close on Monday. Here's a ...

Medpace expects full-year earnings to be $11.93 to $12.69 per share, with revenue in the range of $2.11 billion to $2.21 billion. This story was generated by Automated Insights ( ...

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2024.